文献速递肝病

PNPLA3 rs738409基因多态性与非酒精性脂肪性肝病儿童肾功能下降的关系

Relationship Between PNPLA3 rs738409 Polymorphism and Decreased Kidney Function in Children With NAFLD.
PubMed 文献 · Hepatology · 2019-05-17

该研究纳入142例经活检证实为非酒精性脂肪性肝病(NAFLD)的高加索儿童和青少年,检测PNPLA3 rs738409基因型并评估估算肾小球滤过率(e-GFR)与24小时蛋白尿。结果发现G/G基因型者的e-GFR更低、24小时蛋白尿更高,且在校正年龄、性别、收缩压、肥胖指标、胰岛素抵抗及组织学严重程度后,该关联仍独立存在。

要点

  • G/G基因型儿童e-GFR为107.5±20 mL/min/1.73 m²,低于G/C组的112.8±18和C/C组的125.3±23(P=0.002)。
  • G/G基因型儿童24小时蛋白尿为58.5±21 mg/天,高于G/C组的53.9±22和C/C组的42.9±20(P=0.012)。
  • 校正年龄、性别、收缩压、肥胖指标、胰岛素抵抗及非酒精性脂肪性肝炎和肝纤维化分期后,G/G基因型仍与较低e-GFR和较高24小时蛋白尿独立相关。

核心结论

  • 在经组织学证实为NAFLD的儿童和青少年中,PNPLA3 G/G基因型与肾功能下降和24小时蛋白尿升高强烈相关,且独立于既有的肾脏危险因素和NAFLD的组织学严重程度。

研究设计与样本

  • 研究纳入142例经活检证实为NAFLD的高加索儿童和青少年,就诊于「Bambino Gesù」儿童医院肝病科;采用Bedside Schwartz方程估算e-GFR,用放射免疫分析法测定24小时蛋白尿,用单核苷酸多态性基因分型等位基因鉴别法检测PNPLA3 rs738409基因型。
  • G/G基因型45例,G/C基因型56例,C/C基因型41例。

主要发现

  • G/G基因型儿童e-GFR为107.5±20 mL/min/1.73 m²,低于G/C基因型的112.8±18 mL/min/1.73 m²和C/C基因型的125.3±23 mL/min/1.73 m²(P=0.002)。
  • G/G基因型儿童24小时蛋白尿为58.5±21 mg/天,高于G/C基因型的53.9±22 mg/天和C/C基因型的42.9±20 mg/天(P=0.012)。
  • 校正年龄、性别、收缩压、肥胖指标、稳态模型评估的胰岛素抵抗、活检证实的非酒精性脂肪性肝炎和肝纤维化分期后,rs738409 G/G基因型与较低的e-GFR独立相关(β系数:-23.6;95%CI:-36.3至-10.8;P<0.001)。
  • 校正上述因素后,rs738409 G/G基因型与较高的24小时蛋白尿独立相关(β系数:15.3;95%CI:1.12至30.5;P=0.046)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Emerging evidence suggests that patatin-like phospholipase domain-containing protein-3 (PNPLA3) rs738409 genotype (the major genetic variant associated with susceptibility to nonalcoholic fatty liver disease [NAFLD]) is associated with decreased kidney function in adults. Currently, it is uncertain whether this association also occurs in children/adolescents and whether any association is independent of liver disease severity. We enrolled a sample of 142 Caucasian children and adolescents with biopsy-proven NAFLD, presenting to the Liver Unit of the "Bambino Gesù" Children's Hospital. The glomerular filtration rate (e-GFR) was estimated using the Bedside Schwartz equation, whereas 24-hour proteinuria was measured using a radioimmunoassay method. Genotyping for the PNPLA3 rs738409 genotype was undertaken using the single-nucleotide polymorphism genotyping allelic discrimination method. Overall, 45 children had G/G, 56 had G/C, and 41 had C/C PNPLA3 rs738409 genotype, respectively. Children with G/G genotype had significantly lower e-GFR (107.5 ± 20 versus 112.8 ± 18 versus 125.3 ± 23 mL/min/1.73 m2 , P = 0.002) and higher 24-hour proteinuria (58.5 ± 21 versus 53.9 ± 22 versus 42.9 ± 20 mg/day, P = 0.012) compared with those with either G/C or C/C genotypes. After adjustment for age, sex, systolic blood pressure, measures of adiposity, homeostasis model assessment-estimated insulin resistance and biopsy-confirmed nonalcoholic steatohepatitis and stage of liver fibrosis, the presence of rs738409 G/G genotype was independently associated with both lower e-GFR (β coefficient: -23.6; 95% confidence interval [CI]: -36.3 to -10.8; P < 0.001) and higher 24-hour proteinuria (β coefficient: 15.3; 95% CI: 1.12 to 30.5; P = 0.046). Conclusion: Regardless of established renal risk factors and the histological severity of NAFLD, the PNPLA3 G/G genotype was strongly associated with decreasing kidney function and increasing 24-hour proteinuria in children/adolescents with histologically confirmed NAFLD.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Targher G, Mantovani A, Alisi A, et al. Relationship Between PNPLA3 rs738409 Polymorphism and Decreased Kidney Function in Children With NAFLD. Hepatology. 2019. PMID: 30912854. doi:10.1002/hep.30625

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。